Danazol a new perspective in the treatment of htlv-l associated myelopathy (preliminary report)
Open Access
- 1 September 1992
- journal article
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 50 (3) , 402-403
- https://doi.org/10.1590/s0004-282x1992000300025
Abstract
We investigated the efficacy of danazol treatment in eight patients with HTLV-l associated myelopathy/tropical spastic paraparesis (HAM/TSP). Treatment with danazol yielded clinical improvement of urinary control and gait disturbances in 7 out of the 8 patients. The improvement was noted within 15 days of danazol administration. Analysis of factors of relevance to the clinical improvement with danazol showed that the beneficial response was preferentially found in females.Keywords
This publication has 8 references indexed in Scilit:
- Evidence of preferential female prevalence of HTLV-I associated tropical spastic paraparesis in Bahia-BrazilArquivos de Neuro-Psiquiatria, 1992
- HTLV-I associated myelopathy in salvador (northeastern Brazil)Arquivos de Neuro-Psiquiatria, 1992
- Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM): Treatment with an Anabolic Steroid DanazolAIDS Research and Human Retroviruses, 1991
- Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulinZeitschrift für Neurologie, 1991
- The effect of zidovudine on chronic myelopathy associated with HTLV-1Zeitschrift für Neurologie, 1991
- HTLV-1 antibodies in serum and cerebrospinal fluid in tropical spastic paraparesis in BrazilArquivos de Neuro-Psiquiatria, 1990
- The neuroepidemiology of tropical spastic paraparesisAnnals of Neurology, 1988
- THE INFLUENCE OF THE GONADS AND ADRENAL GLANDS ON THE IMMUNE RESPONSE TO SKIN GRAFTSTransplantation, 1969